November 30, 2020

The Niche

Knoepfler lab stem cell blog

Betty Ogawa

2 min read

There’s a growing stream of stem cell good news of late. Stem cell biotech, TiGenix, reported encouraging Phase 3 allogeneic results on stem cells. A big milestone. I can’t wait to see the actual data. Its product, Cx601, has so far been safe and effective for perianal fistulas in Crohn’s disease. See more from Alexey on this. CIRM has funded the largest public stem cell bank in the world. Want to make a withdrawal? Asterias reported some great news. It’s AST OPC-1 product showed some signs of encouraging efficacy in the …Read More